MAPT and Alzheimer disease: Data from studies conducted in the last decades indicate that in neurodegenerative diseases, and particularly in AD, neuroinflammation is not only an epiphenomenon secondary to Aβ and tau abnormalities, but it is an essential part of the disease pathophysiology.